ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 126 filers reported holding ACCELERON PHARMA INC in Q4 2015. The put-call ratio across all filers is 2.00 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,000 | – | 37 | +270.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 10 | -99.9% | 0.00% | -100.0% |
| Q1 2019 | $594,000 | +70.2% | 12,760 | -3.2% | 0.00% | +50.0% |
| Q2 2017 | $349,000 | 0.0% | 13,186 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $349,000 | +3.9% | 13,186 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $336,000 | -27.1% | 13,186 | -28.9% | 0.00% | -33.3% |
| Q3 2015 | $461,000 | -21.3% | 18,548 | 0.0% | 0.00% | -25.0% |
| Q2 2015 | $586,000 | +31.7% | 18,548 | +58.3% | 0.00% | +33.3% |
| Q1 2015 | $445,000 | -2.4% | 11,717 | 0.0% | 0.00% | -25.0% |
| Q4 2014 | $456,000 | +463.0% | 11,717 | +336.9% | 0.00% | +300.0% |
| Q3 2014 | $81,000 | -11.0% | 2,682 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $91,000 | – | 2,682 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |